113 related articles for article (PubMed ID: 29779766)
1. Should all suspected tuberculosis cases in high income countries be tested with GeneXpert?
Vella V; Broda A; Drobniewski F
Tuberculosis (Edinb); 2018 May; 110():112-120. PubMed ID: 29779766
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of treating multidrug-resistant tuberculosis.
Resch SC; Salomon JA; Murray M; Weinstein MC
PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of a new model for early detection of patients with multidrug-resistant tuberculosis in a developed setting of eastern China.
Liu Z; Pan A; Wu B; Zhou L; He H; Meng Q; Chen S; Pang Y; Wang X
Trop Med Int Health; 2017 Oct; 22(10):1328-1333. PubMed ID: 28746979
[TBL] [Abstract][Full Text] [Related]
4. GeneXpert MTB/RIF Is Superior to BBD Max MDR-TB for Diagnosis of Tuberculosis (TB) in a Country with Low Incidence of Multidrug-Resistant TB (MDR-TB).
Mokaddas EM; Ahmad S; Eldeen HS
J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30971464
[No Abstract] [Full Text] [Related]
5. Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert
Pallas SW; Courey M; Hy C; Killam WP; Warren D; Moore B
Appl Health Econ Health Policy; 2018 Aug; 16(4):537-548. PubMed ID: 29862440
[TBL] [Abstract][Full Text] [Related]
6. Stepwise implementation of a new diagnostic algorithm for multidrug-resistant tuberculosis in Haiti.
Gauthier M; Somoskövi A; Berland JL; Ocheretina O; Mabou MM; Boncy J; Gutierrez C; Vernet G; Pape JW
Int J Tuberc Lung Dis; 2014 Feb; 18(2):220-6. PubMed ID: 24429317
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries.
Acuna-Villaorduna C; Vassall A; Henostroza G; Seas C; Guerra H; Vasquez L; Morcillo N; Saravia J; O'Brien R; Perkins MD; Cunningham J; Llanos-Zavalaga L; Gotuzzo E
Clin Infect Dis; 2008 Aug; 47(4):487-95. PubMed ID: 18636955
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Accuracy of GeneXpert MTB/RIF Assay in Comparison to Conventional Drug Susceptibility Testing Method for the Diagnosis of Multidrug-Resistant Tuberculosis.
Pandey P; Pant ND; Rijal KR; Shrestha B; Kattel S; Banjara MR; Maharjan B; Kc R
PLoS One; 2017; 12(1):e0169798. PubMed ID: 28081227
[TBL] [Abstract][Full Text] [Related]
9. Simple, direct drug susceptibility testing technique for diagnosis of drug-resistant tuberculosis in resource-poor settings.
Kim CK; Joo YT; Lee EP; Park YK; Kim HJ; Kim SJ
Int J Tuberc Lung Dis; 2013 Sep; 17(9):1212-6. PubMed ID: 23823178
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness study of the microbiological diagnosis of tuberculosis using geneXpert MTB/RIF
Herráez Ó; Asencio-Egea MÁ; Huertas-Vaquero M; Carranza-González R; Castellanos-Monedero J; Franco-Huerta M; Barberá-Farré JR; Tenías-Burillo JM
Enferm Infecc Microbiol Clin; 2017; 35(7):403-410. PubMed ID: 27445177
[TBL] [Abstract][Full Text] [Related]
11. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.
Shah NS; Moodley P; Babaria P; Moodley S; Ramtahal M; Richardson J; Heysell S; Li X; Moll A; Friedland G; Sturm AW; Gandhi NR
Am J Respir Crit Care Med; 2011 May; 183(10):1427-33. PubMed ID: 21297071
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of decentralised care model for managing MDR-TB in India.
John D; Chatterjee P; Murthy S; Bhat R; Musa BM
Indian J Tuberc; 2018 Jul; 65(3):208-217. PubMed ID: 29933862
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of GenoType® MTBDRplus assay for rapid detection of drug susceptibility testing of multi-drug resistance tuberculosis in Northern India.
Maurya AK; Umrao J; Singh AK; Kant S; Kushwaha RA; Dhole TN
Indian J Pathol Microbiol; 2013; 56(2):139-43. PubMed ID: 24056651
[TBL] [Abstract][Full Text] [Related]
14. Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.
Chiang TY; Fan SY; Jou R
PLoS One; 2018; 13(7):e0200755. PubMed ID: 30011319
[TBL] [Abstract][Full Text] [Related]
15. Microscopic observation drug-susceptibility assay vs. Xpert
Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
[TBL] [Abstract][Full Text] [Related]
16. A novel automatic molecular test for detection of multidrug resistance tuberculosis in sputum specimen: A case control study.
Li Q; Ou XC; Pang Y; Xia H; Huang HR; Zhao B; Wang SF; Zhao YL
Tuberculosis (Edinb); 2017 Jul; 105():9-12. PubMed ID: 28610793
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and Other Risk Factors for Multi-drug Resistant Tuberculosis in a Mexican Population with Pulmonary Tuberculosis: Case Control Study.
Gómez-Gómez A; Magaña-Aquino M; López-Meza S; Aranda-Álvarez M; Díaz-Ornelas DE; Hernández-Segura MG; Salazar-Lezama MÁ; Castellanos-Joya M; Noyola DE
Arch Med Res; 2015 Feb; 46(2):142-8. PubMed ID: 25704633
[TBL] [Abstract][Full Text] [Related]
18. GeneXpert polymerase chain reaction for spinal tuberculosis: an accurate and rapid diagnostic test.
Held M; Laubscher M; Zar HJ; Dunn RN
Bone Joint J; 2014 Oct; 96-B(10):1366-9. PubMed ID: 25274923
[TBL] [Abstract][Full Text] [Related]
19. The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis.
Oxlade O; Falzon D; Menzies D
Eur Respir J; 2012 Mar; 39(3):626-34. PubMed ID: 21828030
[TBL] [Abstract][Full Text] [Related]
20. Experimental platform utilising melting curve technology for detection of mutations in Mycobacterium tuberculosis isolates.
Broda A; Nikolayevskyy V; Casali N; Khan H; Bowker R; Blackwell G; Patel B; Hume J; Hussain W; Drobniewski F
Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1273-1279. PubMed ID: 29675789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
